Inspire Medical Systems, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Timothy Herbert
- Full Time Employees
- 1,333
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 5500 Wayzata Boulevard Golden Valley MN United States of America 55416
- IPO Date
- May 3, 2018
- CIK
- 0001609550
- Website
- inspiresleep.com
- Similar Companies
- Business
- Inspire Medical Systems, Inc. (NYSE: INSP) develops and commercializes the Inspire therapy, an implantable neurostimulation system designed to treat moderate to severe obstructive sleep apnea (OSA) in adult patients unable to use or get consistent benefit from continuous positive airway pressure (CPAP) devices. The company's core products and services include the Inspire Upper Airway Stimulation (UAS) system, consisting of the Inspire implantable pulse generator (IPG), stimulation lead, sensing lead, and external patient remote control; surgical tools and accessories for implantation; the myInspire patient management platform for remote monitoring and therapy adjustments; and physician and patient education programs supporting therapy adoption. Inspire therapy offers a masked volume reduction alternative to CPAP, with implantation performed by ENTs and sleep surgeons in outpatient procedures; the company provides direct-to-consumer marketing, reimbursement support services, and post-market clinical research through its registry studies. Founded in 2007 and headquartered in Golden Valley, Minnesota, Inspire Medical Systems operates primarily in the United States, with expanding commercial presence in Europe (including select countries via partnerships) and international markets targeting adult OSA patients underserved by traditional therapies. The company serves sleep clinics, ENT practices, hospitals, and sleep surgeons as key customers, focusing on the medical device segment of the sleep health industry valued at billions annually. In recent developments, Inspire Medical Systems reported strong revenue growth in 2025, driven by increased procedure volumes and market adoption; the company expanded its European operations through new regulatory approvals and partnerships in 2024-2025. It launched enhancements to the Inspire therapy platform, including software updates for improved therapy titration and remote monitoring capabilities; additionally, Inspire announced positive results from ongoing post-market studies demonstrating long-term efficacy and safety, supporting expanded indications. No major acquisitions, funding rounds, or name changes were reported in the last 1-2 years, with strategic focus remaining on U.S. market penetration and international scaling.
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors
3 Medical Device Stocks Giving Investors a Different Healthcare Play
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Correction: Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on August 3, 2026
Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026
Inspire Medical Investigation Continued: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Inspire Medical Systems, Inc. - INSP
Inspire Medical Systems, Inc. (INSP) Presents at Wells Fargo 2026 MedTech Innovation Spotlight Transcript
INSP Highlights New OSA Data and PREDICTOR Study at SLEEP 2026
Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study
Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight
Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?
Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff
Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?
Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip
Inspire Medical Q1 Earnings Beat Estimates, 2026 View Cut, Stock Down
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, Devon Energy, GoDaddy, Home Depot, Lam Research, Lowe’s, Roblox, Tractor Supply, Ulta Beauty, and More